LTX-315, Purity ≥98%

Synonym: 1345407-05-7; LTX315; LTX 315; (2S)-2,6-Diamino-N-[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1-oxo-3,3-diphenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]hexanamide

CAS Number: 1345407-05-7
Compound CID: 46200994

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

MSDS

Properties

Description

LTX-315, soluble in water and ethanol, is the oncolytic peptide that kills cancer cells. The molecular weight of the compound is 1439.79, and its molecular formula is C₇₈H₁₀₆N₁₈O₉.

Molecular Weight

1439.79

Molecular Formula

C₇₈H₁₀₆N₁₈O₉

Form

Lyophilized powder

Purity

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: Water: 97 mg/mL (67.37 mM); Ethanol: <1 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

LTX-315 plays a key role in increasing immunogenicity in tumor cells, leading to enhanced anti-tumor immune responses.